new

Get trending papers in your email inbox!

Subscribe

byAK and the research community

Mar 12

PeopleSansPeople: A Synthetic Data Generator for Human-Centric Computer Vision

In recent years, person detection and human pose estimation have made great strides, helped by large-scale labeled datasets. However, these datasets had no guarantees or analysis of human activities, poses, or context diversity. Additionally, privacy, legal, safety, and ethical concerns may limit the ability to collect more human data. An emerging alternative to real-world data that alleviates some of these issues is synthetic data. However, creation of synthetic data generators is incredibly challenging and prevents researchers from exploring their usefulness. Therefore, we release a human-centric synthetic data generator PeopleSansPeople which contains simulation-ready 3D human assets, a parameterized lighting and camera system, and generates 2D and 3D bounding box, instance and semantic segmentation, and COCO pose labels. Using PeopleSansPeople, we performed benchmark synthetic data training using a Detectron2 Keypoint R-CNN variant [1]. We found that pre-training a network using synthetic data and fine-tuning on various sizes of real-world data resulted in a keypoint AP increase of +38.03 (44.43 pm 0.17 vs. 6.40) for few-shot transfer (limited subsets of COCO-person train [2]), and an increase of +1.47 (63.47 pm 0.19 vs. 62.00) for abundant real data regimes, outperforming models trained with the same real data alone. We also found that our models outperformed those pre-trained with ImageNet with a keypoint AP increase of +22.53 (44.43 pm 0.17 vs. 21.90) for few-shot transfer and +1.07 (63.47 pm 0.19 vs. 62.40) for abundant real data regimes. This freely-available data generator should enable a wide range of research into the emerging field of simulation to real transfer learning in the critical area of human-centric computer vision.

Constellation Dataset: Benchmarking High-Altitude Object Detection for an Urban Intersection

We introduce Constellation, a dataset of 13K images suitable for research on detection of objects in dense urban streetscapes observed from high-elevation cameras, collected for a variety of temporal conditions. The dataset addresses the need for curated data to explore problems in small object detection exemplified by the limited pixel footprint of pedestrians observed tens of meters from above. It enables the testing of object detection models for variations in lighting, building shadows, weather, and scene dynamics. We evaluate contemporary object detection architectures on the dataset, observing that state-of-the-art methods have lower performance in detecting small pedestrians compared to vehicles, corresponding to a 10% difference in average precision (AP). Using structurally similar datasets for pretraining the models results in an increase of 1.8% mean AP (mAP). We further find that incorporating domain-specific data augmentations helps improve model performance. Using pseudo-labeled data, obtained from inference outcomes of the best-performing models, improves the performance of the models. Finally, comparing the models trained using the data collected in two different time intervals, we find a performance drift in models due to the changes in intersection conditions over time. The best-performing model achieves a pedestrian AP of 92.0% with 11.5 ms inference time on NVIDIA A100 GPUs, and an mAP of 95.4%.

Find n' Propagate: Open-Vocabulary 3D Object Detection in Urban Environments

In this work, we tackle the limitations of current LiDAR-based 3D object detection systems, which are hindered by a restricted class vocabulary and the high costs associated with annotating new object classes. Our exploration of open-vocabulary (OV) learning in urban environments aims to capture novel instances using pre-trained vision-language models (VLMs) with multi-sensor data. We design and benchmark a set of four potential solutions as baselines, categorizing them into either top-down or bottom-up approaches based on their input data strategies. While effective, these methods exhibit certain limitations, such as missing novel objects in 3D box estimation or applying rigorous priors, leading to biases towards objects near the camera or of rectangular geometries. To overcome these limitations, we introduce a universal Find n' Propagate approach for 3D OV tasks, aimed at maximizing the recall of novel objects and propagating this detection capability to more distant areas thereby progressively capturing more. In particular, we utilize a greedy box seeker to search against 3D novel boxes of varying orientations and depth in each generated frustum and ensure the reliability of newly identified boxes by cross alignment and density ranker. Additionally, the inherent bias towards camera-proximal objects is alleviated by the proposed remote simulator, which randomly diversifies pseudo-labeled novel instances in the self-training process, combined with the fusion of base samples in the memory bank. Extensive experiments demonstrate a 53% improvement in novel recall across diverse OV settings, VLMs, and 3D detectors. Notably, we achieve up to a 3.97-fold increase in Average Precision (AP) for novel object classes. The source code is made available at https://github.com/djamahl99/findnpropagate.

AI in Pharma for Personalized Sequential Decision-Making: Methods, Applications and Opportunities

In the pharmaceutical industry, the use of artificial intelligence (AI) has seen consistent growth over the past decade. This rise is attributed to major advancements in statistical machine learning methodologies, computational capabilities and the increased availability of large datasets. AI techniques are applied throughout different stages of drug development, ranging from drug discovery to post-marketing benefit-risk assessment. Kolluri et al. provided a review of several case studies that span these stages, featuring key applications such as protein structure prediction, success probability estimation, subgroup identification, and AI-assisted clinical trial monitoring. From a regulatory standpoint, there was a notable uptick in submissions incorporating AI components in 2021. The most prevalent therapeutic areas leveraging AI were oncology (27%), psychiatry (15%), gastroenterology (12%), and neurology (11%). The paradigm of personalized or precision medicine has gained significant traction in recent research, partly due to advancements in AI techniques hamburg2010path. This shift has had a transformative impact on the pharmaceutical industry. Departing from the traditional "one-size-fits-all" model, personalized medicine incorporates various individual factors, such as environmental conditions, lifestyle choices, and health histories, to formulate customized treatment plans. By utilizing sophisticated machine learning algorithms, clinicians and researchers are better equipped to make informed decisions in areas such as disease prevention, diagnosis, and treatment selection, thereby optimizing health outcomes for each individual.

Estimating global article processing charges paid to six publishers for open access between 2019 and 2023

This study presents estimates of the global expenditure on article processing charges (APCs) paid to six publishers for open access between 2019 and 2023. APCs are fees charged for publishing in some fully open access journals (gold) and in subscription journals to make individual articles open access (hybrid). There is currently no way to systematically track institutional, national or global expenses for open access publishing due to a lack of transparency in APC prices, what articles they are paid for, or who pays them. We therefore curated and used an open dataset of annual APC list prices from Elsevier, Frontiers, MDPI, PLOS, Springer Nature, and Wiley in combination with the number of open access articles from these publishers indexed by OpenAlex to estimate that, globally, a total of \8.349 billion (8.968 billion in 2023 US dollars) were spent on APCs between 2019 and 2023. We estimate that in 2023 MDPI (\681.6 million), Elsevier (582.8 million) and Springer Nature (\546.6) generated the most revenue with APCs. After adjusting for inflation, we also show that annual spending almost tripled from 910.3 million in 2019 to \$2.538 billion in 2023, that hybrid exceed gold fees, and that the median APCs paid are higher than the median listed fees for both gold and hybrid. Our approach addresses major limitations in previous efforts to estimate APCs paid and offers much needed insight into an otherwise opaque aspect of the business of scholarly publishing. We call upon publishers to be more transparent about OA fees.